title: Prothrombotic changes in children with sickle cell disease: relationships to cerebrovascular disease and transfusion.
abstract: Vascular occlusion has a central role in the pathophysiology of sickle cell disease (SCD) and, although there is little evidence that thrombosis alone is responsible, patients with sickle cell disease are known to have an ill-defined but increased thrombotic risk. The most serious complication of this in childhood is stroke which occurs in 7-10% of children and a further 14% have asymptomatic cerebrovascular disease (CVD) on imaging. We have performed a comprehensive profile of coagulation inhibitors and markers of thrombin generation in 96 children (83 nontransfused [NTx] and 13 transfused [Tx]) with steady-state SCD and 18 healthy sibling controls. The levels of protein S (free and total) and heparin cofactor II were reduced in both the NTx and Tx groups compared to controls and protein C and APC resistance ratios were reduced in the NTx group only. Antithrombin levels were not different from controls. Thrombin-antithrombin complexes and prothrombin fragment F1+2 were increased in both patient groups. In the NTx subgroups with or without CVD there were no differences for any of the parameters measured except for lower haemoglobin levels and higher white cell counts in those with asymptomatic CVD. We conclude that children with SCD have a reduction in levels of the majority of the coagulation inhibitors and increased thrombin generation in the steady-state and these are only partially reversed by transfusion. However, these abnormalities do not appear to play a primary role in the development of cerebrovascular disease.
authors.affiliation: Department of Haematology and Oncology, Great Ormond Street Hospital NHS Trust, London.
authors.forename: R
authors.initials: R
authors.lastname: Liesner
authors.forename: I
authors.initials: I
authors.lastname: Mackie
authors.forename: J
authors.initials: J
authors.lastname: Cookson
authors.forename: S
authors.initials: S
authors.lastname: McDonald
authors.forename: A
authors.initials: A
authors.lastname: Chitolie
authors.forename: S
authors.initials: S
authors.lastname: Donohoe
authors.forename: J
authors.initials: J
authors.lastname: Evans
authors.forename: I
authors.initials: I
authors.lastname: Hann
authors.forename: S
authors.initials: S
authors.lastname: Machin
mesh_terms: D020016:Activated Protein C Resistance / Q000097:blood; D000293:Adolescent; D000755:Anemia, Sickle Cell / Q000097:blood* / Q000150:complications; D017152:Antibodies, Antiphospholipid / Q000097:blood; D000991:Antithrombins / Q000032:analysis; D002561:Cerebrovascular Disorders / Q000097:blood / Q000209:etiology*; D002648:Child; D002675:Child, Preschool; D005260:Female; D015844:Heparin Cofactor II / Q000032:analysis; D006801:Humans; D008297:Male; D011486:Protein C / Q000032:analysis; D017293:Protein S / Q000032:analysis; D011516:Prothrombin / Q000378:metabolism*
chemical_list: D017152:Antibodies, Antiphospholipid; D000991:Antithrombins; D011486:Protein C; D017293:Protein S; D015844:Heparin Cofactor II; D011516:Prothrombin